VivoSim Labs (VIVS) Change in Acquisitions & Divestments (2023 - 2024)
VivoSim Labs (VIVS) posted quarterly Change in Acquisitions & Divestments of -$718000.0 for Q1 2024, down 286.98% year-over-year from $384000.0 in Q2 2023, and down 200.0% quarter-over-quarter from $718000.0 in Q2 2023.
VivoSim Labs (VIVS) Change in Acquisitions & Divestments (2023 - 2024) Analysis & Trends
VivoSim Labs' Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at -$718000.0 for Q1 2024.
- In Q1 2024, Change in Acquisitions & Divestments fell 286.98% year-over-year to -$718000.0; the TTM figure through Dec 2023 stood at $1.1 million (changed N/A YoY), while the FY2023 annual figure was $384000.0, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q1 2024 stood at -$718000.0, down from $718000.0 in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $718000.0 in Q2 2023, with the low at -$718000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -718,000.00 |
| Mar 31, 2024 | -718,000.00 |
| Jun 30, 2023 | 718,000.00 |
| Jun 30, 2023 | 718,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Mar 31, 2023 | 384,000.00 |